Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer.
Samaneh TokhanbigliAli AsadiradKaveh BaghaeiAndrea PiccinFatemeh YarianGilda ParsamaneshSeyed Mahmoud HashemiHamid Asadzadeh AghdaeiMohammad Reza ZaliPublished in: ImmunoTargets and therapy (2020)
In conclusion, based on the overexpression of LY6E in colorectal, gastric, and pancreatic cancers, the role of this peptide should be further investigated with a goal of developing new therapies for these challenging diseases.